$7.20
-0.20-2.70%
Pre-Market: 6:51 AM EDT
Comments
Loading...
Actuate Therapeutics Stock Price, Quotes and Forecasts
ACTUNASDAQ
Actuate Therapeutics (ACTU) Forecast
NewsEarningsActuate Therapeutics (ACTU) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Actuate Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:ACTU | Benzinga
Explore Actuate Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ACTU.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Actuate Therapeutics (ACTU) stock?
You can purchase shares of Actuate Therapeutics (NASDAQ:ACTU) through any online brokerage.
Who are Actuate Therapeutics (ACTU) competitors?
Other companies in Actuate Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Zentalis Pharma (NASDAQ:ZNTL), Genelux (NASDAQ:GNLX) and RAPT Therapeutics (NASDAQ:RAPT).
What is the forecast, or price target, for Actuate Therapeutics (ACTU) stock?
Actuate Therapeutics has a consensus price target of $20.00.
What is the current price for Actuate Therapeutics (ACTU)?
The stock price for Actuate Therapeutics (NASDAQ: ACTU) is $7.2 last updated March 18, 2025 at 6:51 AM EDT.
Does Actuate Therapeutics (ACTU) pay a dividend?
There are no upcoming dividends for Actuate Therapeutics.
When is Actuate Therapeutics (NASDAQ:ACTU) reporting earnings?
Actuate Therapeutics’s Q1 earnings are confirmed for Wednesday, May 21, 2025.
Is Actuate Therapeutics (ACTU) going to split?
There is no upcoming split for Actuate Therapeutics.
What sector and industry does Actuate Therapeutics (ACTU) operate in?
Actuate Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.